Candapi
CanDapi develops and produces a new type of innovative single dose for multi-use Dry Powder Inhaler (DPI) platform for delivering medications, including cannabinoids to the lungs in the form of a dry powder for various treatments. In addition, CanDapi develops a new line of delivery platforms to the lungs and nose for capsuled drugs in powder or liquid forms Our Solution - A new method of medicine inhalation, developed by CanDapi, in the form of totally new patented inhalers- The new CanDapi DPI is operated using high-frequency vibrations activated by inhaling. This method is an exceptional and innovative drug delivery mechanism with tested results of over 85% efficiency by Kiel University, Germany, and efficiency of medical CBD powder of 92% as tested by Cannasoul Analytics (The Technion company)- The most effective platform for new drugs including biopharmaceutics- The safest and most effective platform suitable for the efficient delivery of cannabinoid powder ingredients- The perfect solution for more effective treatment for lung diseases such as asthma and COPD (Chronic Obstructive Pulmonary Disease).
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Candapi
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Candapi
1 distinct titles indexed · top 1 shown.
- 1ceo
Sign up to unlock all 1 contacts at Candapi
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Candapi
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.